Skip to main content

Advertisement

Log in

Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Venous thromboembolism (VTE) is a known cause of morbidity in the oncology patient population. As hospital readmission rates are more frequently scrutinized, we sought to determine the most common causes of 30-day readmissions in the cancer patient following abdominopelvic surgery. Furthermore, due to the high risk of VTE, there have been guidelines established for prophylaxis. As guidelines are based on asymptomatic VTE, we studied the compliance rates of these guidelines in our institution and the rate of symptomatic VTE in the 30-day postoperative period.

Methods

We conducted a retrospective chart review at Pennsylvania Hospital of abdominopelvic surgeries between January 1, 2010 and December 31, 2012 in patients with abdominopelvic malignancies, totaling 263 patients.

Results

The median age of our patient population was 67 years and 51.3 % were female. The most common malignancy locations were colorectal (44 %) and pancreas (11 %). One patient did not receive perioperative anticoagulation; most received heparin subcutaneously three times daily, mean duration 5.5 days. Fourteen patients (5 %) received outpatient anticoagulation after discharge; only two had a primary intent of VTE prophylaxis. Thirty-five patients (13 %) were readmitted within 30 days of discharge, the most common reasons being abdominal symptoms and postoperative/surgical complications. There was one patient readmitted for a new, symptomatic VTE.

Conclusions

Our study showed only one new, symptomatic VTE in the study population, despite 95 % of patients not receiving outpatient anticoagulation, which suggests that continued larger and multicenter trials may be needed to study anticoagulation benefits and risks in this patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

VTE:

Venous thromboembolism

ASCO:

American Society of Clinical Oncology

UFH:

Unfractionated heparin

LMWH:

Low-molecular-weight heparin

DVT:

Deep venous thrombosis

UPHS:

University of Pennsylvania Health System

IRB:

Internal review board

BMI:

Body mass index

PE:

Pulmonary embolism

NOS:

Not otherwise specified

g:

Grams

dL:

Deciliter

L:

Liter

mg:

Milligrams

ACCP:

American College of Chest Physicians

References

  1. Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E, Moia M, Parazzini F, Rossi R, Sonaglia F, Valarani B, Bianchini C, Gussoni G (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243:89–95

    Article  PubMed Central  PubMed  Google Scholar 

  2. Khorana AA (2012) Cancer-associated thrombosis: updates and controversies. In: Burns LJ (ed) Hematology Am Soc Hematol Educ Program 2012. American Society of Hematology, Rochester, pp 626–630

    Google Scholar 

  3. Elting LS, Escalante CP, Cooksley C, Avritscher EB, Kurtin D, Hamblin L, Khosla SG, Rivera E (2004) Outcomes and cost of deep vein thrombosis among patients with cancer. Arch Intern Med 164:1653–1661

    Article  PubMed  Google Scholar 

  4. Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE, Kakkar AK, Key NS, Levine MN, Liebman HA, Tempero MA, Wong SL, Prestrud AA, Falanga A (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2189–2204

    Article  CAS  PubMed  Google Scholar 

  5. Rasmussen MS, Jorgensen LN, Wille-Jorgenson P (2009) Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 1, CD004318

    PubMed  Google Scholar 

  6. Akl EA, Terrenato I, Barba M, Sperati F, Muti P, Schunemann HJ (2008) Extended perioperative thromboprophylaxis in patients with cancer: a systematic review. Thromb Haemost 100:1176–1180

    CAS  PubMed  Google Scholar 

  7. Stefan MS, Pekow PS, Nsa W, Priya A, Miller LE, Bratzler DW, Rothberg MB, Goldberg RJ, Baus K, Lindenauer PK (2013) Hospital performance measures and 30-day readmission rates. J Gen Intern Med 28:377–385

    Article  PubMed Central  PubMed  Google Scholar 

  8. Schneider EB, Hyder O, Brooke BS, Efron J, Cameron JL, Edil BH, Schulick RD, Choti MA, Wolfgang CL, Pawlik TM (2012) Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg 214:390–398

    Article  PubMed  Google Scholar 

  9. Martin RC, Brown R, Puffer L, Block S, Callender G, Quillo A, Scoggins CR, McMasters KM (2011) Readmission rates after abdominal surgery: the role of surgeon, primary caregiver, home health, and subacute rehab. Ann Surg 254:591–597

    Article  PubMed  Google Scholar 

  10. Rosemurgy AS, Luberice K, Paul H, Co F, Vice M, Toomey P, Choung E, Ross SB (2012) Readmissions after pancreaticoduodenectomy: efforts need to focus on patient expectations and nonhospital medical care. Am Surg 78:837–843

    PubMed  Google Scholar 

  11. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e227S–277S

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Davenport DL, Vargas HD, Kasten MW, Xenos ES (2012) Timing and perioperative risk factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer resection. Clin Appl Thromb Hemost 18:569–575

    Article  PubMed  Google Scholar 

  13. Toledano TH, Kondal D, Kahn SR, Tagalakis V (2013) The occurrence of venous thromboembolism in cancer patients following major surgery. Thromb Res 131:e1–e5

    Article  CAS  PubMed  Google Scholar 

  14. Smith BR, Diniz S, Stamos M, Nguyen NT (2011) Deep venous thrombosis after general surgical operations at a university hospital: two-year data from the ACS NSQIP. Arch Surg 146:1424–1427

    Article  PubMed  Google Scholar 

  15. Varpe P, Huhtinen H, Rantala A, Gronross J (2009) Thromboprophylaxis following surgery for colorectal cancer – is it worthwhile after hospital discharge? Scand J Surg 98:58–61

    CAS  PubMed  Google Scholar 

  16. Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902–4907

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Michota FA (2009) Prevention of venous thromboembolism after surgery. Cleve Clin J Med 76:S45–S52

    Article  PubMed  Google Scholar 

  18. Bradley CT, Brasel KJ, Miller JJ, Pappas SG (2010) Cost-effectiveness of prolonged thromboprophylaxis after cancer surgery. Ann Surg Oncol 17:31–39

    Article  PubMed  Google Scholar 

  19. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355:1295–1302

    Article  Google Scholar 

  20. Anderson DR, Dunbar MJ, Bohm ER, Belzile E, Kahn SR, Zukor D, Fisher W, Gofton W, Gross P, Pelet S, Crowther M, MacDonald S, Kim P, Pleasance S, Davis N, Andreou P, Wells P, Kovacs M, Rodger MA, Ramsay T et al (2013) Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med 158:800–806

    Article  PubMed  Google Scholar 

  21. Bilimoria KY, Chung J, Ju MH, Haut ER, Bentrem DJ, Ko CY, Baker DW (2013) Evaluation of surveillance bias and the validity of the venous thromboembolism quality measure. JAMA 310:1482–1489

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

Authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christine Klimowicz White.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

White, C.K., Langholtz, J., Burns, Z.T. et al. Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review. Support Care Cancer 23, 993–999 (2015). https://doi.org/10.1007/s00520-014-2448-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-014-2448-0

Keywords

Navigation